Programs in this model generally bundle a virtual clinical evaluation, provider-issued prescriptions, and either brand-name FDA-approved GLP-1 dispensing or compounded semaglutide/tirzepatide through licensed compounding-pharmacy pathways
These are not the same thing, and understanding the difference changes how you evaluate the formulation
Dosage protocols vary, but most research references: Weekly dosing Gradual titration from lower mg levels to 20mg Subcutaneous injection methods similar to GLP-1 medications Because the compound is extremely potent, dose escalation is essential to minimise side effects
One advantage of 3.33mg/mL is how well it scales across vial sizes
Symptoms of B12 deficiency can include fatigue, weakness, pale or jaundiced skin, shortness of breath, and neurological issues such as numbness or tingling in the hands and feet